This is a non-inferiority trial design comparing colorectal cancer incidence in trial participants with 1-2 non-advanced adenomas randomized to recommendation for a 5- and 10-year surveillance colonoscopy exam vs. a 10-year surveillance colonoscopy exam.
Funder: National Cancer Institute
Investigator: Corley, Douglas
|
A Kaiser Permanente interregional cancer statistics report will be developed to include incidence and 5-year relative survival rates for breast, colorectal, and lung cancer. The development of new mortality measures will be explored, along with improved r...
Funder: Center for Effectiveness and Safety Research
Investigator: Kushi, Lawrence
|
We are using post-polypectomy surveillance, an increasingly common indication for colonoscopy in clinical practice at TPMG and across the United States, as a model for how we might risk-stratify patients for care. Patients and physicians desire more preci...
Funder: The Permanente Medical Group
Investigator: Levin, Theodore
|
|
Among colon cancer patients participating in a resistance training intervention during chemotherapy, this study will examine whether a new method to evaluate skeletal muscle mass (d3-creatine dilution) is associated with the key cancer outcomes of stre...
Funder: National Cancer Institute
Investigator: Feliciano, Elizabeth
|
|
To prioritize pediatric attended polysomnography and treatment for children most in need while reducing the unnecessary use of overnight sleep studies, we propose to build and rigorously evaluate a clinical risk prediction model. We will combine data f...
Funder: The Permanente Medical Group
Investigator: Feliciano, Elizabeth
|
To strengthen the dietary guidelines for breast cancer survivors, we examine whether at-diagnosis concordance with healthful dietary patterns is associated with recurrence or breast cancer death, or with prognostic biomarkers (i.e., body composition, infl...
Funder: American Institute for Cancer Research
Investigator: Feliciano, Elizabeth
|
The goal of this project is to describe the normative distributions of pubertal development among boys and girls by race/ethnicity and to investigate early-life risk factors affecting pubertal onset and tempo (velocity of transition between onset and matu...
Funder: National Institute of Child Health and Human Development
Investigator: Kubo, Ai
|
The New-Onset Diabetes Cohort Study is designed to help develop and test early detection tests and processes. Kaiser Permanente Northern California is collaborating in this multi-site study to identify, recruit, and follow up with members who have recentl...
Funder: National Cancer Institute
Investigator: Van Den Eeden, Stephen
|
This study evaluates the safety and efficacy in reducing recurrence of Clostridium difficile infection in adults who had a recurrence within 8 weeks of receiving CP101 or placebo in PRISM3. Subjects who are experiencing recurrent Clostridium difficile inf...
Funder: Finch Research and Development, LLC
Investigator: Levin, Theodore
|
This monthly webinar series, attended by approximately 200 people from diverse disciplines, is ongoing and focuses on topics relevant to body composition and cancer. The Division of Research will host 10 webinar speakers who are prominent in the field; ar...
Funder: National Cancer Institute
Investigator: Caan, Bette
|
Aim 1: Determine associations among body mass index (BMI), body composition variables, and tumor subtype. The amount and quality of muscle, visceral adipose tissue, and subcutaneous adipose tissue will be derived from existing pre-surgical CT scans; a...
Funder: National Cancer Institute
Investigator: Caan, Bette
|
This funding expands on neighborhood resources developed under the U01 grant (geocoded residential histories, linkage to census and area databases, virtual neighborhood audits). Aim 1: Develop methods to use remote sensing data and machine learning te...
Funder: National Cancer Institute
Investigator: Kushi, Lawrence
|
The objectives of this Phase 2 study are to evaluate the safety and tolerability of CP101 treatment compared to placebo in adults with previously treated, recurrent Clostridium difficile infection, and to evaluate the efficacy of CP101 treatment relative ...
Funder: Finch Research and Development, LLC
Investigator: Levin, Theodore
|
The goals of this study are to evaluate associations between: 1) immigrant status and social networks at the neighborhood level and at the individual level, overall and by race/ethnicity, further evaluating associations among Asian/Pacific Islander an...
Funder: National Cancer Institute
Investigator: Kroenke, Candyce
|
This project builds on a previous Community Benefit grant award to examine changes in cervical and colorectal cancer screening as a result of the implementation of the Patient Protection and Affordable Care Act. It will exami...
Funder: National Institute of Environmental Health Sciences
Investigator: Kushi, Lawrence
|
This is a retrospective case-control study to examine the timing and magnitude of loss of muscle and adiposity prior to diagnosis of pancreatic cancer.
Funder: Dana Farber Cancer Institute
Investigator: Caan, Bette
|
Genetic risk and family history, which includes personal medical history, increasingly influence medical care, but optimal methods for capturing the hereditary risk of disease and the outcomes of such assessments are unknown. Using inherited cancer as a m...
Funder: Patient-Centered Outcomes Research Institute
Investigator: Corley, Douglas
|
As part of a “K” training award from the National Institutes of Health, and within the overall colorectal cancer research program at Kaiser Permanente Northern California, this project will support additional analyses regarding the identification of perso...
Funder: National Cancer Institute
Investigator: Corley, Douglas
|
This project will validate whether a clinical tool can predict the presence of Barrett's esophagus and the development of esophageal adenocarcinoma.
Funder: U.S. Department of Veterans Affairs
Investigator: Corley, Douglas
|
|
This project expands a consortium of studies examining germline genetic mutations in breast cancer risk in Latinas. It builds on a study that will include approximately 550 Latina women with breast cancer in the Pathways Study; genetic data from Latin...
Funder: National Cancer Institute
Investigator: Kushi, Lawrence
|
|
This study aims to: 1) assess reproductive intentions and receipt of fertility counseling or preservation in relation to post-diagnosis birth outcomes among adolescent and young adult cancer survivors in North Carolina and the Kaiser Permanente N...
Funder: University of North Carolina
Investigator: Kushi, Lawrence
|
|
Screening has been shown to reduce colorectal cancer incidence and mortality. However, screening has resulted in a growing cohort of patients with adenomatous polyps (adenomas), and little is known about effectively managing their post-polypectomy sur...
Funder: National Cancer Institute
Investigator: Lee, Jeffrey
|
The goal of the PROCEED study is to determine the early markers or predictors of progression among individuals with pancreatitis. Participants will undergo focused study-related procedures and questionnaires at enrollment and regularly during follow-up as...
Funder: National Institutes of Health
Investigator: Van Den Eeden, Stephen
|
The NOD (New-Onset Diabetes) Cohort Study is part of a multisite effort to create a cohort with strictly defined new-onset diabetes. Kaiser Permanente Northern California is also receiving funding from the National Cancer Institute Community Oncology Rese...
Funder: National Institute of Diabetes and Digestive and Kidney Diseases
Investigator: Van Den Eeden, Stephen
|
This project consists of development of electronic tools to rapidly assess body composition in colorectal cancer and breast cancer patients and present this information to clinicians. It leverages Kaiser Permanente Northern California’s electronic medical...
Funder: National Cancer Institute
Investigator: Feliciano, Elizabeth
|
|
